Zobrazeno 1 - 10
of 13
pro vyhledávání: '"M B, Comerford"'
Publikováno v:
Clinical Cardiology. 7:23-28
Prenalterol is an orally active cardioselective beta agonist, with a long half-life. Previous studies have confirmed its inotropic activity following intravenous infusion in patients with heart failure. It has little chronotropic activity and no sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366de88bc099bcdd28cb92a147788546
https://doi.org/10.1002/clc.4960070106
https://doi.org/10.1002/clc.4960070106
Autor:
M. B. Comerford
Publikováno v:
Clinical Cardiology. 1:130-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8f02c3fec1f325478b206044533b250
https://doi.org/10.1002/clc.4960010302
https://doi.org/10.1002/clc.4960010302
Publikováno v:
Heart. 35:320-333
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e2b100c25042dcac0b543c36fc3c81
https://doi.org/10.1136/hrt.35.3.320
https://doi.org/10.1136/hrt.35.3.320
Autor:
M. B. Comerford, E. M. M. Besterman
Publikováno v:
Scottish Medical Journal. 22:80-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ed3ec543c31804b771d909f33dfa1c
https://doi.org/10.1177/003693307702200121
https://doi.org/10.1177/003693307702200121
Autor:
D. V. Hamilton, P. C. Barnes, R. M. L. Bowles, D. V. Rajaratnam, M. B. Comerford, W. R. Ginks, S. E. Ginks, J. R. Goves, W. J. Grabau, J. P. Malcolm, R. J. Hadley, R. J. Hopkins, D. M. Lawrie, J. B. Stoker, C. A. Morley, N. C. Taylor, F. D. Thompson, J. C. Kingswood, R. A. Elton, E. A. Forret
Publikováno v:
Journal of Cardiovascular Pharmacology. 10:S111-113
The role of felodipine, a new calcium antagonist, in monotherapy for mild and moderate hypertension was investigated in a placebo-controlled double-blind study of 109 patients from 13 centres. The patients were randomised in a double-blind fashion to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50a5c2acb109192e019525b0f597b36b
https://doi.org/10.1097/00005344-198706110-00040
https://doi.org/10.1097/00005344-198706110-00040
Autor:
D V, Hamilton, P C, Barnes, R M, Bowles, D V, Rajaratnam, M B, Comerford, W R, Ginks, S E, Ginks, J R, Goves, W J, Grabau, J P, Malcolm
Publikováno v:
Journal of cardiovascular pharmacology. 10
The role of felodipine, a new calcium antagonist, in monotherapy for mild and moderate hypertension was investigated in a placebo-controlled double-blind study of 109 patients from 13 centres. The patients were randomised in a double-blind fashion to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f88521aff44420b9742a533f1e552a70
https://pubmed.ncbi.nlm.nih.gov/2455107
https://pubmed.ncbi.nlm.nih.gov/2455107
Publikováno v:
The Journal of international medical research. 4(1)
Ten patients with typical angina pectoris and without hypertension, congestive heart failure or other disease were treated with alternating four-week courses of metoprolol ( a β1 cardioselective beta-blocking agent), propranolol and placebo. Midway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e393aced0c2b9d83927c0edce98146c4
https://pubmed.ncbi.nlm.nih.gov/799974
https://pubmed.ncbi.nlm.nih.gov/799974
Autor:
M. B. Comerford, E. M. Besterman
Publikováno v:
Postgraduate medical journal. 52(610)
Summary Following an initial dose response study, metoprolol, a selective beta1-receptor blocking agent, was compared with equipotent dosages of propanolol in a double blind cross-over study, including exercise tolerance tests, on fourteen patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8e47feee137326cf1d4168d84a01f7
https://pubmed.ncbi.nlm.nih.gov/10564
https://pubmed.ncbi.nlm.nih.gov/10564
Autor:
M B, Comerford, E M, Besterman
Publikováno v:
Annals of clinical research. 14(1)
The therapeutic control of blood pressure and heart rate throughout the 24 hour period, was assessed in ten hypertensive patients, following the administration of placebo, conventional metoprolol 100 mg twelve hourly, and the slow release formulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc0359c2f01a8688e2aa23c7802d3d79
https://pubmed.ncbi.nlm.nih.gov/7137874
https://pubmed.ncbi.nlm.nih.gov/7137874